Emcure Pharmaceuticals Ltd

NSE: EMCURE · BSE: 544210 · Pharmaceuticals & Biotechnology · 47 announcements

Emcure Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,905.90
Market cap: ₹36,157 Cr
Revenue (annual): ₹9,204 Cr
Net profit (annual): ₹924.4 Cr
P/E (TTM): 35.8×Sector 47.4×
Promoter holding: 77.83%-0.04% QoQ
FII holding: 4.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 6 Management Change 6 Earnings Call 6 Annual General Meeting 6 Other Announcement 5 Financial Results 4 Board Meeting Date 4 Employee Stock Options 3 Business Update 2 Share Pledge 1 Regulatory Approval 1 Dividend 1 Credit Rating 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 May 2026 18:03 IST NSE

Dividend

Emcure Pharmaceuticals Dividend

Emcure Pharmaceuticals Limited recommended a final dividend of ₹0.36 per equity share for the financial year 2025-26. The dividend is subject to shareholder approval at the upcoming Annual General Meeting. The record date and AGM date will be communicated in due course.

Read the filing ↗